SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-023620
Filing Date
2020-05-08
Accepted
2020-05-08 16:47:35
Documents
64
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q clsd-10q_20200331.htm 10-Q 1104084
2 EX-10.1 clsd-ex101_89.htm EX-10.1 42028
3 EX-10.2 clsd-ex102_178.htm EX-10.2 428260
4 EX-31.1 clsd-ex311_9.htm EX-31.1 16724
5 EX-31.2 clsd-ex312_8.htm EX-31.2 16494
6 EX-32.1 clsd-ex321_6.htm EX-32.1 9042
7 GRAPHIC gyjpe5kihne4000001.jpg GRAPHIC 28582
  Complete submission text file 0001564590-20-023620.txt   4943984

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT clsd-20200331.xml EX-101.INS 841509
9 XBRL TAXONOMY EXTENSION SCHEMA clsd-20200331.xsd EX-101.SCH 43744
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clsd-20200331_cal.xml EX-101.CAL 34658
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clsd-20200331_def.xml EX-101.DEF 139786
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE clsd-20200331_lab.xml EX-101.LAB 338921
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clsd-20200331_pre.xml EX-101.PRE 256238
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 20861334
SIC: 2834 Pharmaceutical Preparations